AP24534 is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia.
Domain | ap24534inhibitor.com |
---|---|
Homepage URL | https://ap24534inhibitor.com/endocervical-microglandular-hyperplasia-colposcopic-features-physiopathology-as-well-as-differential-prognosis/ |
Keywords | ap24534 inhibitor signaling pathway gastroenterology research |
Sprache | englisch |